Skip to main content
Clinical Trials/IRCT201402234010N11
IRCT201402234010N11CompletedPhase 2

Evaluation of The Effects of vitamin D3 supplementation on Irritable bowel syndrome symptoms

ational Nutrition and Food Technology Research Institute (NNFTRI)0 sites66 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
66

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Inclusion criteria: age between 18 to 65 years old; serum level of 25(OH)D under 30 ng/ml; evidence of having irritable bowel syndrome using Rome III Criteria; not having Vitamin D supplementation since one year ago; not having a history of alcohol drink; not suffering from other organic diseases of the intestine, bowel surgery, breast; cancer, severe mental illness; not pregnant, breastfeeding and professional sports; not taking Non-steroidal anti-inflammatory drug ( NSAIDs), laxatives, nicotine, artificial sweeteners, antibiotics, immunomodulators or repression, intestinal bleeding, drugs, fish oils and digestive movements modifier.
  • Exclusion criteria: their unwillingness to continue the study for any reason; pregnancy.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
ational Nutrition and Food Technology Research Institute (NNFTRI)

Similar Trials